European cancer mortality predictions for the year 2016 with focus on leukaemias

Annals of Oncology

Volumn 27, Issue 4, 2016, Pages 725-731

  Malvezzi, M ^a,b   Carioli, G ^b   Bertuccio, P ^b   Rosso, T ^b   Boffetta, P ^c   Levi, F ^d   La Vecchia, C ^b   Negri, E ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Cancer; Europe; Leukaemia; Mortality; Projections; Time trends

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; COLORECTAL CANCER; CONTROLLED STUDY; EUROPEAN UNION; FEMALE; HUMAN; INFANT; LEUKEMIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; SEX DIFFERENCE; STOMACH CANCER; TREND STUDY; UTERUS CANCER; AGE; CHILD; CLASSIFICATION; EPIDEMIOLOGY; EUROPE; FORECASTING; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS;

ADULT; AGE FACTORS; AGED; CHILD; EUROPE; FEMALE; FORECASTING; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; PROGNOSIS;

EID: 84964647508     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdw022     Document Type: Article

References (43)

1. Malvezzi M, Arfe A, Bertuccio P et al. European cancer mortality predictions for the year 2011. Ann Oncol 2011; 22: 947-956.
2. Malvezzi M, Bertuccio P, Levi F et al. European cancer mortality predictions for the year 2012. Ann Oncol 2012; 23: 1044-1052.
3. Malvezzi M, Bertuccio P, Levi F et al. European cancer mortality predictions for the year 2013. Ann Oncol 2013; 24: 792-800.
4. Malvezzi M, Bertuccio P, Levi F et al. European cancer mortality predictions for the year 2014. Ann Oncol 2014; 25: 1650-1656.
5. Malvezzi M, Bertuccio P, Rosso T et al. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? Ann Oncol 2015; 26: 779-786.
6. World Health Organization Statistical Information System. WHO Mortality Database. http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html 2015 (15 May 2015, date last accessed).
7. Doll R, Smith PG, Waterhouse JAH et al. Comparison between registries: agestandardized rates. Vol. IV. IARC Sci Publ No. 42. In Cancer Incidence in Five Continents. 1982; 671-675.
8. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. (Erratum in: Stat Med 2001; 20: 655). Stat Med 2000; 19: 335-351.
9. Faraway JJ. Linear Models with R. Texts in Statistical Science. Vol. 63. Boca Raton: Chapman & Hall/CRC 2005.
10. European Commission. Eurostat Population Database. http://ec.europa.eu/ eurostat/data/database 2014 (24 July 2014, date last accessed).
11. European Commission. Eurostat statistics explained. Population structure and ageing. 2014. http://ec.europa.eu/eurostat/statistics-explained/index.php/Population_ structure_and_ageing (5 February 2016, date last accessed).
12. Gallus S, Lugo A, La Vecchia C et al. Pricing Policies And Control of Tobacco in Europe (PPACTE) project: cross-national comparison of smoking prevalence in 18 European countries. Eur J Cancer Prev 2014; 23: 177-185.
13. Bosetti C, Malvezzi M, Rosso T et al. Lung cancer mortality in European women: trends and predictions. Lung Cancer 2012; 78: 171-178.
14. Parazzini F, La Vecchia C, Negri E et al. Reproductive factors and risk of endometrial cancer. Am J Obstet Gynecol 1991; 164: 522-527.
15. Bosetti C, Bertuccio P, Chatenoud L et al. Trends in mortality from urologic cancers in Europe, 1970-2008. Eur Urol 2011; 60: 1-15.
16. Cuzick J, Thorat MA, Andriole G et al. Prevention and early detection of prostate cancer. Lancet Oncol 2014; 15: e484-e492.
17. Ait Ouakrim D, Pizot C, Boniol M et al. Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database. BMJ 2015; 351: h4970.
18. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet 2014; 383: 1490-1502.
19. Peleteiro B, La Vecchia C, Lunet N. The role of Helicobacter pylori infection in the web of gastric cancer causation. Eur J Cancer Prev 2012; 21: 118-125.
20. Ferro A, Peleteiro B, Malvezzi M et al. Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. Eur J Cancer 2014; 50: 1330-1344.
21. Malvezzi M, Bonifazi M, Bertuccio P et al. An age-period-cohort analysis of gastric cancer mortality from 1950 to 2007 in Europe. Ann Epidemiol 2010; 20: 898-905.
22. Rosato V, Polesel J, Bosetti C et al. Population attributable risk for pancreatic cancer in Northern Italy. Pancreas 2015; 44: 216-220.
23. Fernandez E, La Vecchia C, Decarli A. Attributable risks for pancreatic cancer in northern Italy. Cancer Epidemiol Biomarkers Prev 1996; 5: 23-27.
24. Duell EJ. Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer. Mol Carcinog 2012; 51: 40-52.
25. Bracci PM. Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Mol Carcinog 2012; 51: 53-63.
26. Bosetti C, Bertuccio P, Chatenoud L et al. Childhood cancer mortality in Europe, 1970-2007. Eur J Cancer 2010; 46: 384-394.
27. Juliusson G, Karlsson K, Lazarevic V et al. Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: realworld population-based data from the Swedish Acute Leukemia Registry 1997-2006. Cancer 2011; 117: 4238-4246.
28. Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med 2015; 373: 1541-1552.
29. Ibrahim A, Ali A, Mohammed MM. Outcome of adolescents with acute lymphoblastic leukemia treated by pediatrics versus adults protocols. Adv Hematol 2014; 2014: 697675.
30. Pui CH, Pei D, Campana D et al. Improved prognosis for older adolescents with acute lymphoblastic leukemia. J Clin Oncol 2011; 29: 386-391.
31. Taga T, Tomizawa D, Takahashi H, Adachi S. Acute myeloid leukemia in children -Current status and future directions. Pediatr Int 2015 Dec 8 [epub ahead of print], doi: 10.1111/ped.12865.
32. Pidala J, Djulbegovic B, Anasetti C et al. Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission. Cochrane Database Syst Rev 2011; CD008818.
33. Sweet K, Lancet JE. Novel therapeutics in acute myeloid leukemia. Curr Hematol Malig Rep 2014; 9: 109-117.
34. Estey EH. How to manage high-risk acute myeloid leukemia. Leukemia 2012; 26: 861-869.
35. Dohner H, Weisdorf DJ, Bloomfield CD. Acute Myeloid Leukemia. N Engl J Med 2015; 373: 1136-1152.
36. Jabbour E, Cortes JE, Giles FJ et al. Current and emerging treatment options in chronic myeloid leukemia. Cancer 2007; 109: 2171-2181.
37. Apperley JF. Chronic myeloid leukaemia. Lancet 2015; 385: 1447-1459.
38. Kantarjian H, O'Brien S, Jabbour E et al. Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience. Blood 2012; 119: 1981-1987.
39. Breccia M, Tiribelli M, Alimena G. Tyrosine kinase inhibitors for elderly chronic myeloid leukemia patients: a systematic review of efficacy and safety data. Crit Rev Oncol Hematol 2012; 84: 93-100.
40. Brenner H, Gondos A, Pulte D. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood 2008; 111: 4916-4921.
41. Wall S, Woyach JA. Chronic lymphocytic leukemia and other lymphoproliferative disorders. Clin Geriatr Med 2016; 32: 175-189.
42. Goede V, Fischer K, Busch R et al. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. N Engl J Med 2014; 370: 1101-1110.
43. Moller B, Fekjaer H, Hakulinen T et al. Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med 2003; 22: 2751-2766.